Skip to main content
Caplight Logo









Multiomic Health

Multiomic Health

Private
LondonHealthcare & Life Scienceshttps://multiomic.health/

Last Round

Seed

May 4, 2023

Total Funding Raised

$8.6M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Multiomic Health is a biotechnology company that develops an AI-enabled drug discovery platform for precision medicine to address metabolic syndrome-related diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Precision Medicine, Medical AI, Biotechnology, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

drug discoveryprecision medicineAI drug discoverymulti-omicssystems biologycompanion diagnosticsCDxbiomarker discoverymetabolic diseasepatient stratificationin silico drug discoverytherapeutic target identificationAI-native biotechlongitudinal patient datatechbio

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Multiomic Health Comparables

Compare Multiomic Health with similar companies based on industry and business-model similarity.

Multiomic Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Relation Therapeutics
83%
Ochre Bio
83%
Valinor Discovery
82%

Multiomic Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 4, 2023
SeedMay 1, 2021

Key People

Founding team and executive leadership

Robert Thong

Co-Founder Chief Executive Officer

Founding Team

Multiomic Health Investors

Notable investors and investment history

Multiomic Health investors
InvestorRounds
Verve VenturesSeed
Ada VenturesSeed
Hoxton VenturesSeed
MMC VenturesSeed
Fifty YearsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 21, 2026

    Monthly visitors increased 39% MoM, from 2.9K to 4K.

  • Apr 2, 2025

    Collaborating with Alloy Therapeutics on renal tissue-targeting drugs.

Multiomic Health Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Multiomic Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Multiomic Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range15
Year Founded2021
Last FundingMay 4, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?